AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing
AbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance. The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's Business Daily.
AbbVie stock slipped Thursday despite a second-quarter beat that included strong Skyrizi sales and a boost to 2024 earnings guidance.
The post AbbVie Is About To Have A New Golden Goose As Humira Sales Continue Slowing appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
